Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fasudil - Raya Therapeutic

Next Previous
Drug Profile

Fasudil - Raya Therapeutic

Alternative Names: RT-1968

Latest Information Update: 02 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University Medical Center Gottingen
  • Developer Raya Therapeutic; University Medical Center Gottingen
  • Class 1 ring heterocyclic compounds; Anti-ischaemics; Aza compounds; Ischaemic heart disorder therapies; Isoquinolines; Small molecules; Sulfonamides
  • Mechanism of Action Calcium channel antagonists; Protein kinase C inhibitors; Rho-associated kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Amyotrophic lateral sclerosis

Most Recent Events

  • 02 Jan 2025 Chemical structure information added.
  • 18 Jun 2024 Raya Therapeutic in-licenses Fasudil from University Medical Center Gottingen
  • 17 Jun 2024 Adverse events and efficacy data from the phase-IIa ROCK-ALS trial in Amyotrophic lateral sclerosis released by Raya Therapeutic

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top